Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14984051 | 0.95 | ACHE (0.66) | ACHEEPHX1EPHX2 | |
| SCHEMBL13660364 | 0.88 | ACHE (0.53) | ACHEEPHX1EPHX2 | |
| SCHEMBL25477800 | 0.86 | ACHE (0.58) | ACHEEPHX1EPHX2 | |
| SCHEMBL9773856 | 0.86 | ACHE (0.55) | ACHE | |
| SCHEMBL9774144 | 0.86 | ACHE (0.62) | ACHEEPHX1 | |
| SCHEMBL25477796 | 0.85 | ACHE (0.49) | ACHEEPHX1 | |
| SCHEMBL17549418 | 0.85 | ACHE (0.54) | ACHE | |
| Hydrochloric Acid SCHEMBL9774200 | 0.85 | ACHE (0.58) | ACHEEPHX1EPHX2 | |
| Hydrochloric Acid SCHEMBL10457841 | 0.84 | ACHE (0.60) | ACHEEPHX1 | |
| SCHEMBL10639959 | 0.84 | ACHE (0.60) | ACHEEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9234067-B2 | Material forming supramolecular structures, process and uses | HENKEL AG & CO. KGAA (DE) | 2016-01-12 | — | — | US | disclosed |
| EP-1792925-B1 | Novel material forming supramolecular structures, process and uses | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-1792925-B1 | Novel material forming supramolecular structures, process and uses | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-20080200718-A1 | Reacting (thio)isocyanate with amine, alcohol or thiol | HENKEL KGAA (DE) | 2008-08-21 | — | — | US | disclosed |
| US-20080200718-A1 | Reacting (thio)isocyanate with amine, alcohol or thiol | HENKEL KGAA (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1792925-A1 | Novel material forming supramolecular structures, process and uses | National Starch and Chemical Investment Holding Corporation (US) | 2007-06-06 | — | — | EP | disclosed |
| EP-1792925-A1 | Novel material forming supramolecular structures, process and uses | National Starch and Chemical Investment Holding Corporation (US) | 2007-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200718-A1 | Reacting (thio)isocyanate with amine, alcohol or thiol | TST, CBR3, TBCB | ACHE 3588/4885EPHX1 2249/4885EPHX2 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.